Simplex Trading’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,600
| Closed | -$34K | – | 10346 |
|
|
2023
Q4 | $34K | Buy |
2,600
+2,000
| +333% | +$25.3K | ﹤0.01% | 6467 |
|
|
2023
Q3 | $7K | Sell |
600
-500
| -45% | -$6.05K | ﹤0.01% | 7492 |
|
|
2023
Q2 | $13K | Sell |
1,100
-85,100
| -99% | -$1.06M | ﹤0.01% | 7211 |
|
|
2023
Q1 | $1.06M | Buy |
86,200
+21,600
| +33% | +$254K | ﹤0.01% | 2542 |
|
|
2022
Q4 | $740K | Buy |
64,600
+58,700
| +995% | +$483K | ﹤0.01% | 2771 |
|
|
2022
Q3 | $22K | Sell |
5,900
-8,000
| -58% | -$36.9K | ﹤0.01% | 7446 |
|
|
2022
Q2 | $82K | Sell |
13,900
-2,600
| -16% | -$14.7K | ﹤0.01% | 5837 |
|
|
2022
Q1 | $104K | Buy |
16,500
+14,600
| +768% | +$82K | ﹤0.01% | 6087 |
|
|
2021
Q4 | $7K | Buy |
+1,900
| New | +$8.25K | ﹤0.01% | 9378 |
|
|
2021
Q2 | – | Sell |
-15
| Closed | -$9K | – | 11147 |
|
|
2021
Q1 | $9K | Sell |
15
-86
| -85% | -$615 | ﹤0.01% | 7992 |
|
|
2020
Q4 | $69K | Buy |
101
+62
| +159% | +$306 | ﹤0.01% | 5836 |
|
|
2020
Q3 | $15K | Buy |
+39
| New | +$143 | ﹤0.01% | 6595 |
|
|
2020
Q2 | – | Sell |
-71
| Closed | -$15K | – | 8863 |
|
|
2020
Q1 | $15K | Sell |
71
-7
| -9% | -$20 | ﹤0.01% | 6208 |
|
|
2019
Q4 | $24K | Buy |
78
+68
| +680% | +$272 | ﹤0.01% | 5830 |
|
|
2019
Q3 | $4K | Buy |
+10
| New | +$50 | ﹤0.01% | 6761 |
|
|
2018
Q4 | – | Sell |
-6
| Closed | -$2K | – | 8480 |
|
|
2018
Q3 | $2K | Buy |
6
+1
| +20% | +$4 | ﹤0.01% | 7151 |
|
|
2018
Q2 | $1K | Buy |
+5
| New | +$33 | ﹤0.01% | 7264 |
|
|
2018
Q1 | – | Sell |
-15
| Closed | -$4K | – | 7501 |
|
|
2017
Q4 | $4K | Buy |
+15
| New | +$140 | ﹤0.01% | 4823 |
|
|
2017
Q3 | – | Sell |
-124
| Closed | -$37K | – | 7226 |
|
|
2017
Q2 | $37K | Sell |
124
-69
| -36% | -$1.41K | ﹤0.01% | 2686 |
|
|
2017
Q1 | $69K | Buy |
193
+157
| +436% | +$3.93K | ﹤0.01% | 2073 |
|
|
2016
Q4 | $45K | Buy |
36
+32
| +800% | +$1.36K | ﹤0.01% | 2261 |
|
|
2016
Q3 | $2K | Sell |
4
-7
| -64% | -$291 | ﹤0.01% | 5170 |
|
|
2016
Q2 | $31K | Buy |
11
+2
| +22% | +$109 | ﹤0.01% | 2508 |
|
|
2016
Q1 | $16K | Sell |
9
-1
| -10% | -$52 | ﹤0.01% | 3039 |
|
|
2015
Q4 | $3K | Sell |
10
-27
| -73% | -$1.9K | ﹤0.01% | 4386 |
|
|
2015
Q3 | $33K | Buy |
+37
| New | +$3.02K | ﹤0.01% | 2327 |
|
|
2015
Q1 | – | Sell |
-2
| Closed | -$1K | – | 6056 |
|
|
2014
Q4 | $1K | Buy |
+2
| New | +$146 | ﹤0.01% | 4462 |
|
Simplex Trading's MACK Position: Q4 2022 in Review
Simplex Trading sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2022, closing a stake of 8,692 shares — an estimated $71.6K sold.
Simplex Trading first reported a position in MACK in Q2 2015 and held it in 19 quarters. The position peaked at $470K in Q3 2016. 47 funds tracked by Wall St. Rank hold MACK as of Q4 2022.
- Simplex Trading reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
- Simplex Trading sold 8,692 Merrimack Pharmaceuticals, Inc. shares in Q4 2022, an estimated $71.6K.
- Simplex Trading first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2015 and held it in 19 quarters.
- Simplex Trading's Merrimack Pharmaceuticals, Inc. position peaked at $470K in Q3 2016.
- 47 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2022.
Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.